Chronic myeloid leukaemia: open trials in United Kingdom

12 open trials have a site in United Kingdom. Registry data; only the trial team decides who can take part.

NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
London · Oxford
Registry updated 2026-11-09
NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
University Hospitals of Leicester NHS Trust, Leicester · St Bartholomews Hospital, London · University Hospitals Plymouth NHS Trust, Plymouth
Registry updated 2026-11-04
NCT06163430
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
Trial Treatment · Phase 1/2 · Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Imperial College Healthcare NHS Trust, London
Registry updated 2026-10-15
NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Trial Treatment · Phase 1/2 · Incyte Biosciences International Sàrl
Royal Hospital For Sick Children Yorkhill Glasgow, Glasgow · Alder Hey Childrens Nhs Foundation Trust, Liverpool · The Royal Marsden NHS Foundation Trust - Sutton, Sutton
Registry updated 2026-10-09
NCT04256317
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Trial Treatment · Phase 2/3 · Taiho Oncology, Inc.
King's College Hospital NHS Foundation Trust, London · Maidstone and Tunbridge Wells NHS Trust - Maidstone Hospital, Maidstone · The Christie NHS Foundation Trust, Manchester · Oxford University Hospitals NHS Foundation Trust, Oxford · University Hospital Southampton NHS Foundation Trust, Southampton
Registry updated 2026-10-06
NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Trial Treatment · Phase 2 · Cogent Biosciences, Inc.
Leeds Teaching Hospitals NHS Trust, Leeds · University College London Hospital NHS Foundation Trust, London · Guy's Hospital - NHS Foundation Trust, London
Registry updated 2026-09-15
NCT06423911
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Trial Treatment · Phase 3 · Ascentage Pharma Group Inc.
Aberdeen · Birmingham · Boston · Bradford · Liverpool · London · London · Newport
Registry updated 2026-09-15
NCT07033598
Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
Trial Treatment · Phase 2 · Theradex
King's College Hospital NHS Foundation Trust, London · The Christie NHS Foundation Trust, Manchester
Registry updated 2026-08-18
NCT04581512
Study to Evaluate the Safety and Tolerability of EP0042
Trial Treatment · Phase 1/2 · Ellipses Pharma
University College London Hospital, London · The Royal Marsden, London · The Christie Hospital, Manchester
Registry updated 2026-06-22
NCT04888741
Methods of T Cell Depletion Trial (MoTD)
Trial Treatment · Phase 2 · University of Birmingham
Queen Elizabeth Hospital, Birmingham · Bristol Haematology and Oncology Centre, Bristol · Addenbrookes Hospital, Cambridge · University Hospital of Wales, Cardiff · Queen Elizabeth Hospital Glasgow, Glasgow · St Jame's University Hospital, Leeds · King's College Hospital, London · Hammersmith Hospital, London · University College London Hospital, London · The Christie, Manchester · Manchester Royal Infirmary, Manchester · Freeman Hospital, Newcastle upon Tyne · Nottingham City Hospital, Nottingham · Churchill Hospital, Oxford · Derriford Hospital, Plymouth · Royal Hallamshire Hospital, Sheffield · The Royal Marsden Hospital, Sutton
Registry updated 2026-05-05
NCT05304377
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Trial Treatment · Phase 1 · Enliven Therapeutics
Beatson West of Scotland Cancer Centre, Gartnavel General Hospital,, Glasgow · Hammersmith Hospital, Imperial College Healthcare NHS Trust, London · The Christie NHS Foundation Trust, Manchester
Registry updated 2026-04-01
NCT06355583
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
Trial Treatment · Phase 2 · Imperial College London
University Hospitals Birmingham NHS Foundation Trust, Birmingham · Leeds Teaching Hospital NHS Trust, Leeds · University College London Hospitals NHS Trust, London · Royal Mardsen Hostpital, London · Imperial College Healthcare NHS Trust, London · Kings College NHS Foundation Trust, London · Manchester University NHS Trust, Manchester · Manchester University NHS Foundation Trust, Manchester
Registry updated 2025-04-17

All Chronic myeloid leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error